Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3093 |
|
Actual shortage: | 247 (8%) | |
Anticipated shortage: | 14 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2823 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-LORAZEPAM | 2MG | TABLET | Resolved | 2021-12-01 | 2021-12-20 | 150252 |
APO-DEFERASIROX (TYPE J) | 360MG | TABLET | Resolved | 2021-12-03 | 2021-12-20 | 150432 |
APO-PANTOPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2021-12-03 | 2022-02-14 | 150435 |
APO-RIVASTIGMINE | 6MG | CAPSULE | Resolved | 2021-12-03 | 2021-12-13 | 150440 |
APO-METFORMIN ER | 1000MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-12-09 | 2022-01-24 | 150839 |
APO-SAXAGLIPTIN | 5MG | TABLET | Resolved | 2021-12-10 | 2022-01-31 | 150896 |
APO-SILDENAFIL | 100MG | TABLET | Resolved | 2021-12-10 | 2021-12-22 | 150899 |
APO-SILDENAFIL | 50MG | TABLET | Resolved | 2021-12-10 | 2021-12-22 | 150910 |
APO-ATORVASTATIN | 40MG | TABLET | Avoided shortage | 2021-12-17 | 2022-01-18 | 151342 |
APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2021-12-17 | 2022-03-29 | 151345 |
APO-MIRTAZAPINE | 30MG | TABLET | Resolved | 2021-12-17 | 2022-01-06 | 151347 |
APO-RASAGILINE | 0.5MG | TABLET | Resolved | 2021-12-17 | 2022-09-01 | 151360 |
APO-RASAGILINE | 1MG | TABLET | Resolved | 2021-12-17 | 2022-09-01 | 151367 |
APO-CILAZAPRIL | 5MG | TABLET | Resolved | 2021-12-24 | 2022-04-04 | 151883 |
APO-DOXYLAMINE/B6 | 10MG 10MG | TABLET (DELAYED-RELEASE) | Resolved | 2021-12-24 | 2022-04-14 | 151886 |
APO-OXYCODONE CR | 10MG | TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE) | Resolved | 2021-12-24 | 2022-03-21 | 151889 |
APO-SALBUTAMOL HFA | 100MCG | METERED-DOSE AEROSOL | Resolved | 2021-12-24 | 2021-12-31 | 151892 |
APO-ATOMOXETINE | 10MG | CAPSULE | Resolved | 2022-01-07 | 2022-03-28 | 152295 |
APO-AZITHROMYCIN Z | 250MG | TABLET | Resolved | 2022-01-07 | 2022-03-21 | 152298 |
APO-DESVENLAFAXINE | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-01-07 | 2022-01-24 | 152301 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
IBUPROFEN | 200MG | TABLET | Discontinued | 2019-01-07 | 2019-07-22 | 71439 |
IBUPROFEN CAPLETS | 400MG | TABLET | Discontinued | 2019-01-07 | 2019-07-13 | 71451 |
APO-DILTIAZ CD | 300MG | CAPSULE (CONTROLLED-DELIVERY) | Discontinued | 2019-02-01 | 2019-02-02 | 74366 |
APO-LOSARTAN | 25MG | TABLET | Discontinued | 2019-02-01 | 2019-02-02 | 74376 |
APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78141 | ||
APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78144 | ||
APO-NEVIRAPINE XR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2019-03-11 | 2019-03-11 | 78257 |
APO-RISPERIDONE | 1MG | SOLUTION | To be discontinued | 2019-03-11 | 2019-03-11 | 78260 |
APO-SOLIFENACIN | 10MG | TABLET | Discontinued | 2019-03-11 | 2019-09-20 | 78269 |
APO-SOLIFENACIN | 5MG | TABLET | Discontinued | 2019-03-11 | 2019-09-20 | 78272 |
APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83971 | ||
APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83976 | ||
APO-AMOXI CLAV 250MG/62.5MG PER 5ML | Discontinued | 2019-05-13 | 2019-05-13 | 83981 | ||
APO-AMOXI CLAV | Discontinued | 2019-05-17 | 2019-05-18 | 84392 | ||
APO-CEFPROZIL | Discontinued | 2019-05-17 | 2019-05-18 | 84396 | ||
APO-CEFPROZIL | Discontinued | 2019-06-12 | 2019-06-12 | 86542 | ||
APO-CIPROFLOX | Discontinued | 2019-06-12 | 2019-06-12 | 86547 | ||
APO-EXEMESTANE | Discontinued | 2019-06-12 | 2019-06-12 | 86552 | ||
APO-GEMFIBROZIL CAP 300MG USP | Discontinued | 2019-06-12 | 2019-06-12 | 86557 | ||
TIGECYCLINE | 50MG | POWDER FOR SOLUTION | To be discontinued | 2019-06-21 | 2019-06-21 | 87218 |